Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass.–(BUSINESS WIRE)–X-Chem, Inc. (X-Chem), the global leader in DNA-encoded small molecule library screening and drug discovery, announced today that…
WALTHAM, Mass.–(BUSINESS WIRE)–X-Chem, Inc. (X-Chem), the global leader in DNA-encoded small molecule library screening and drug discovery, announced today that…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX) today announced that its work to pioneer upstream therapeutic approaches to improve…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX) today announced that its work to pioneer upstream therapeutic approaches to improve…
— Randomized controlled trial will add to results from prior open-label trial and in-practice case series — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics…
— Randomized controlled trial will add to results from prior open-label trial and in-practice case series — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…
– Enrollment continues with multiple trial sites now opening across the U.S. – BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc.,…
– Enrollment continues with multiple trial sites now opening across the U.S. – BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc.,…